Polymicrobial biofilms in cystic fibrosis – the role of atypical bacteria in the consortia and impact in antibiotic treatment
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/1822/31572 |
Resumo: | Cystic Fibrosis (CF) is characterized by high rates of morbidity and mortality caused by pulmonary microbial infections. Pseudomonas aeruginosa is typically the prevailing pathogen in the airways of CF patients. However, an emergent and diverse microbial community inhabiting CF lungs has been disclosed, but how it interacts and contributes to the polymicrobial consortia with CF-common pathogens is still to be revealed. The mail goal of this study was to address the behavior of two CF-atypical bacteria, Inquilinus limosus (IL) and Dolosigranulum pigrum (DP), when associated to P. aeruginosa (PA) under oxygen-atmospheres resembling CF airways. For this, those bacteria were grown in dual- and three-species populations with P. aeruginosa in variable oxygen conditions and biofilms were thoroughly characterized for biomass, activity, CFU numbers, antibiotic resistance profiles and relative distributions of bacterial populations. Dual-species consortia were of difficult eradication, with most antibiotics being ineffective in reducing biofilm-bacteria, particularly under low-oxygen atmospheres. Regarding microbial composition, these biofilms presented similar bacterial proportions, whereas P. aeruginosa and D. pigrum dominated the three-species consortia, with I. limosus being the smallest representative population. In general, biofilm compositions changed as a result of antibiotic treatment, with alterations being dependent on the antibiotic, concentration and oxygen condition implemented. P. aeruginosa and I. limosus dual-biofilms exhibited higher antibiotic resistance, with I. limosus persisting and occupying a significant portion together with P. aeruginosa in the overall biofilm after antibiotic treatment. Interestingly, the three-species biofilms displayed higher sensitivity, with D. pigrum and/or P. aeruginosa dominating and I. limosus populations declining in most cases. This suggests that the preponderance of D. pigrum in the biofilm was decisive to decrease I. limosus and lead to an increase in overall sensitivity of the biofilm to a large number of antibiotics. PNA FISH allowed the direct observation of the location and distribution of the three-species species within the biofilms, corroborating the dominance of D. pigrum and P. aeruginosa within the mixed-species consortia and facilitating the understanding of the real complex interactions among the bacterial species. Data highlighted that emergent species are able to establish polymicrobial consortia with common pathogens in the airways of CF patients, modulating different social activities into those communities and impacting the CF therapeutics. |
id |
RCAP_2616967cf45e3398f1e36ab3f4d07b34 |
---|---|
oai_identifier_str |
oai:repositorium.sdum.uminho.pt:1822/31572 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Polymicrobial biofilms in cystic fibrosis – the role of atypical bacteria in the consortia and impact in antibiotic treatmentCystic fibrosisPolymicrobial infectionBiofilmInquilinus limosusDolosigranulum pigrumCystic Fibrosis (CF) is characterized by high rates of morbidity and mortality caused by pulmonary microbial infections. Pseudomonas aeruginosa is typically the prevailing pathogen in the airways of CF patients. However, an emergent and diverse microbial community inhabiting CF lungs has been disclosed, but how it interacts and contributes to the polymicrobial consortia with CF-common pathogens is still to be revealed. The mail goal of this study was to address the behavior of two CF-atypical bacteria, Inquilinus limosus (IL) and Dolosigranulum pigrum (DP), when associated to P. aeruginosa (PA) under oxygen-atmospheres resembling CF airways. For this, those bacteria were grown in dual- and three-species populations with P. aeruginosa in variable oxygen conditions and biofilms were thoroughly characterized for biomass, activity, CFU numbers, antibiotic resistance profiles and relative distributions of bacterial populations. Dual-species consortia were of difficult eradication, with most antibiotics being ineffective in reducing biofilm-bacteria, particularly under low-oxygen atmospheres. Regarding microbial composition, these biofilms presented similar bacterial proportions, whereas P. aeruginosa and D. pigrum dominated the three-species consortia, with I. limosus being the smallest representative population. In general, biofilm compositions changed as a result of antibiotic treatment, with alterations being dependent on the antibiotic, concentration and oxygen condition implemented. P. aeruginosa and I. limosus dual-biofilms exhibited higher antibiotic resistance, with I. limosus persisting and occupying a significant portion together with P. aeruginosa in the overall biofilm after antibiotic treatment. Interestingly, the three-species biofilms displayed higher sensitivity, with D. pigrum and/or P. aeruginosa dominating and I. limosus populations declining in most cases. This suggests that the preponderance of D. pigrum in the biofilm was decisive to decrease I. limosus and lead to an increase in overall sensitivity of the biofilm to a large number of antibiotics. PNA FISH allowed the direct observation of the location and distribution of the three-species species within the biofilms, corroborating the dominance of D. pigrum and P. aeruginosa within the mixed-species consortia and facilitating the understanding of the real complex interactions among the bacterial species. Data highlighted that emergent species are able to establish polymicrobial consortia with common pathogens in the airways of CF patients, modulating different social activities into those communities and impacting the CF therapeutics.Universidade do MinhoLopes, Susana PatríciaAzevedo, N. F.Pereira, Maria Olívia20142014-01-01T00:00:00Zconference objectinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/1822/31572engLopes, Susana Patrícia; Azevedo, N. F.; Pereira, M. O., Polymicrobial biofilms in cystic fibrosis – the role of atypical bacteria in the consortia and impact in antibiotic treatment. ICAR 2014 - III International Conference on Antimicrobial Research. Madrid, Spain, Oct. 1-3, 231-2312014.http://www.icar-2014.org/info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-05-11T07:30:51Zoai:repositorium.sdum.uminho.pt:1822/31572Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-05-11T07:30:51Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Polymicrobial biofilms in cystic fibrosis – the role of atypical bacteria in the consortia and impact in antibiotic treatment |
title |
Polymicrobial biofilms in cystic fibrosis – the role of atypical bacteria in the consortia and impact in antibiotic treatment |
spellingShingle |
Polymicrobial biofilms in cystic fibrosis – the role of atypical bacteria in the consortia and impact in antibiotic treatment Lopes, Susana Patrícia Cystic fibrosis Polymicrobial infection Biofilm Inquilinus limosus Dolosigranulum pigrum |
title_short |
Polymicrobial biofilms in cystic fibrosis – the role of atypical bacteria in the consortia and impact in antibiotic treatment |
title_full |
Polymicrobial biofilms in cystic fibrosis – the role of atypical bacteria in the consortia and impact in antibiotic treatment |
title_fullStr |
Polymicrobial biofilms in cystic fibrosis – the role of atypical bacteria in the consortia and impact in antibiotic treatment |
title_full_unstemmed |
Polymicrobial biofilms in cystic fibrosis – the role of atypical bacteria in the consortia and impact in antibiotic treatment |
title_sort |
Polymicrobial biofilms in cystic fibrosis – the role of atypical bacteria in the consortia and impact in antibiotic treatment |
author |
Lopes, Susana Patrícia |
author_facet |
Lopes, Susana Patrícia Azevedo, N. F. Pereira, Maria Olívia |
author_role |
author |
author2 |
Azevedo, N. F. Pereira, Maria Olívia |
author2_role |
author author |
dc.contributor.none.fl_str_mv |
Universidade do Minho |
dc.contributor.author.fl_str_mv |
Lopes, Susana Patrícia Azevedo, N. F. Pereira, Maria Olívia |
dc.subject.por.fl_str_mv |
Cystic fibrosis Polymicrobial infection Biofilm Inquilinus limosus Dolosigranulum pigrum |
topic |
Cystic fibrosis Polymicrobial infection Biofilm Inquilinus limosus Dolosigranulum pigrum |
description |
Cystic Fibrosis (CF) is characterized by high rates of morbidity and mortality caused by pulmonary microbial infections. Pseudomonas aeruginosa is typically the prevailing pathogen in the airways of CF patients. However, an emergent and diverse microbial community inhabiting CF lungs has been disclosed, but how it interacts and contributes to the polymicrobial consortia with CF-common pathogens is still to be revealed. The mail goal of this study was to address the behavior of two CF-atypical bacteria, Inquilinus limosus (IL) and Dolosigranulum pigrum (DP), when associated to P. aeruginosa (PA) under oxygen-atmospheres resembling CF airways. For this, those bacteria were grown in dual- and three-species populations with P. aeruginosa in variable oxygen conditions and biofilms were thoroughly characterized for biomass, activity, CFU numbers, antibiotic resistance profiles and relative distributions of bacterial populations. Dual-species consortia were of difficult eradication, with most antibiotics being ineffective in reducing biofilm-bacteria, particularly under low-oxygen atmospheres. Regarding microbial composition, these biofilms presented similar bacterial proportions, whereas P. aeruginosa and D. pigrum dominated the three-species consortia, with I. limosus being the smallest representative population. In general, biofilm compositions changed as a result of antibiotic treatment, with alterations being dependent on the antibiotic, concentration and oxygen condition implemented. P. aeruginosa and I. limosus dual-biofilms exhibited higher antibiotic resistance, with I. limosus persisting and occupying a significant portion together with P. aeruginosa in the overall biofilm after antibiotic treatment. Interestingly, the three-species biofilms displayed higher sensitivity, with D. pigrum and/or P. aeruginosa dominating and I. limosus populations declining in most cases. This suggests that the preponderance of D. pigrum in the biofilm was decisive to decrease I. limosus and lead to an increase in overall sensitivity of the biofilm to a large number of antibiotics. PNA FISH allowed the direct observation of the location and distribution of the three-species species within the biofilms, corroborating the dominance of D. pigrum and P. aeruginosa within the mixed-species consortia and facilitating the understanding of the real complex interactions among the bacterial species. Data highlighted that emergent species are able to establish polymicrobial consortia with common pathogens in the airways of CF patients, modulating different social activities into those communities and impacting the CF therapeutics. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014 2014-01-01T00:00:00Z |
dc.type.driver.fl_str_mv |
conference object |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/1822/31572 |
url |
http://hdl.handle.net/1822/31572 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Lopes, Susana Patrícia; Azevedo, N. F.; Pereira, M. O., Polymicrobial biofilms in cystic fibrosis – the role of atypical bacteria in the consortia and impact in antibiotic treatment. ICAR 2014 - III International Conference on Antimicrobial Research. Madrid, Spain, Oct. 1-3, 231-2312014. http://www.icar-2014.org/ |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
mluisa.alvim@gmail.com |
_version_ |
1817545343903989760 |